The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study, Brain, vol.128, issue.5, pp.1093-1101, 2005. ,
Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline, Brain, vol.137, issue.4, pp.1167-1175, 2014. ,
Prediction of amyloidosis from neuropsychological and mri data for cost effective inclusion of pre-symptomatic subjects in clinical trials, Deep Learning in Medical Image Analysis and Multimodal Learning for Clinical Decision Support, pp.357-364, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01578422
Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures, Neurology, vol.84, issue.7, pp.729-737, 2015. ,
DOI : 10.1212/wnl.0000000000001231
URL : http://europepmc.org/articles/pmc4336101?pdf=render
Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls, NeuroImage, vol.145, pp.137-165, 2017. ,
,
Morris. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease, New England Journal of Medicine, vol.367, issue.9, pp.795-804, 2012. ,
A New Regulatory Road-Map for Alzheimer's Disease Drug Development, Current Alzheimer research, vol.11, issue.3, pp.215-220, 2014. ,
Random forests. Machine learning, vol.45, pp.5-32, 2001. ,
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical alzheimer's disease, Neuroimage Clin, vol.2, pp.356-365, 2013. ,
Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation, NeuroImage, vol.46, issue.3, pp.749-761, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00805390
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-? plaques: a prospective cohort study, The Lancet Neurology, vol.11, issue.8, pp.669-678, 2012. ,
A few useful things to know about machine learning, Communications of the ACM, vol.55, issue.10, p.78, 2012. ,
Phase 3 trials of solanezumab for mild-to-moderate alzheimer's disease, New England Journal of Medicine, vol.370, issue.4, pp.311-321, 2014. ,
Alzheimer's disease: Definition, natural history, and diagnostic criteria, Alzheimer's & Dementia, vol.12, issue.3, pp.292-323, 2016. ,
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol.13, issue.4, pp.454-467, 2017. ,
Subgroup identification from randomized clinical trial data, Statistics in Medicine, vol.30, issue.24, pp.2867-2880, 2011. ,
DOI : 10.1002/sim.4322
URL : http://europepmc.org/articles/pmc3880775?pdf=render
Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters, NeuroImage, vol.50, issue.3, pp.883-892, 2010. ,
Greedy function approximation: A gradient boosting machine, The Annals of Statistics, vol.29, issue.5, pp.1189-1232, 2001. ,
Additive logistic regression: a statistical view of boosting. The annals of statistics, vol.28, pp.337-407, 2000. ,
DOI : 10.1214/aos/1016218223
URL : https://doi.org/10.1214/aos/1016218223
Regularization paths for generalized linear models via coordinate descent, Journal of statistical software, vol.33, issue.1, p.1, 2010. ,
DOI : 10.18637/jss.v033.i01
URL : https://www.jstatsoft.org/index.php/jss/article/view/v033i01/v33i01.pdf
Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, issue.5054, pp.184-185, 1992. ,
Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends in Pharmacological Sciences, vol.12, pp.383-388, 1991. ,
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics, Science, vol.297, issue.5580, pp.353-356, 2002. ,
On the mean accuracy of statistical pattern recognizers, IEEE Transactions on Information Theory, vol.14, issue.1, pp.55-63, 1968. ,
Fast and robust fixed-point algorithms for independent component analysis, IEEE Transactions on Neural Networks, vol.10, issue.3, pp.626-634, 1999. ,
DOI : 10.1109/72.761722
URL : http://www.cs.helsinki.fi/u/ahyvarin/papers/TNN99_reprint.pdf
Assessing risk for preclinical ?-amyloid pathology with APOE, cognitive, and demographic information, vol.4, pp.76-84, 2016. ,
DOI : 10.1016/j.jalz.2016.06.1089
Hypothetical model of dynamic biomarkers of the alzheimer's pathological cascade, Lancet Neurology, vol.9, issue.1, p.119, 2010. ,
, Creighton Statistical Methods in Medical Research, 2019.
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease, Alzheimer's & Dementia, vol.14, issue.4, pp.535-562, 2018. ,
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings, Brain, vol.138, issue.12, pp.3747-3759, 2015. ,
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Nature Reviews Drug Discovery, vol.10, issue.9, pp.698-712, 2011. ,
The alzheimer's prevention initiative generation program: Evaluating cnp520 efficacy in the prevention of alzheimer's disease. The journal of prevention of Alzheimer's disease, vol.4, pp.242-246, 2017. ,
Indicators of amyloid burden in a populationbased study of cognitively normal elderly, Neurology, vol.79, issue.15, pp.1570-1577, 2012. ,
Active Clinical Trials for Personalized Medicine, Journal of the American Statistical Association, vol.111, issue.514, pp.875-887, 2016. ,
An introduction to kernel-based learning algorithms, IEEE Transactions on Neural Networks, vol.12, issue.2, pp.181-201, 2001. ,
High performance plasma amyloid-? biomarkers for Alzheimer's disease, Nature, vol.554, issue.7691, pp.249-254, 2018. ,
Amyloid imaging for dementia in clinical practice, BMC Medicine, p.13, 2015. ,
Performance guarantees for individualized treatment rules, The Annals of Statistics, vol.39, issue.2, pp.1180-1210, 2011. ,
DOI : 10.1214/10-aos864
URL : https://doi.org/10.1214/10-aos864
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease, New England Journal of Medicine, vol.370, issue.4, pp.322-333, 2014. ,
Design of a Bayesian adaptive phase 2 proofof-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease, Statistical Methods in Medical Research, vol.2, issue.1, pp.1-12, 2016. ,
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects, Annals of neurology, vol.65, issue.4, pp.403-413, 2009. ,
DOI : 10.1002/ana.21610
URL : http://europepmc.org/articles/pmc2696350?pdf=render
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, vol.7, pp.280-292, 2011. ,
, MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimer's Research & Therapy, vol.10, p.100, 2018.
Neuroimaging Predictors of Brain Amyloidosis in Mild Cognitive Impairment, Annals of neurology, vol.74, issue.2, pp.188-198, 2013. ,
Obstacles And Opportunities In Alzheimer's Clinical Trial Recruitment, vol.33, pp.574-579, 2014. ,
DOI : 10.1377/hlthaff.2013.1314
URL : https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2013.1314
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations, Assessment & Disease Monitoring, vol.1, issue.3, pp.358-367, 2015. ,
The Supervised Learning No-Free-Lunch Theorems, Soft Computing and Industry, pp.25-42, 2002. ,
No Free Lunch Theorems for Optimization, IEEE TRANSACTIONS ON EVOLUTIONARY COMPUTATION, vol.1, issue.1, p.16, 1997. ,
Estimating Individualized Treatment Rules Using Outcome Weighted Learning, Journal of the American Statistical Association, vol.107, issue.499, pp.1106-1118, 2012. ,
DOI : 10.1080/01621459.2012.695674
URL : http://europepmc.org/articles/pmc3636816?pdf=render